Medicinova Income Statement (2010-2025) | MNOV

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Shares Outstanding (Entity) (Quarter)
48.77M48.92M49.03M49.04M49.04M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.22M
Revenue & cost
Revenue (Quarter)
4.00M0.04M1.00M0.13M0.12M0.15M
Gross Profit (Quarter)
0.02M0.01M0.00M
Operating items
Research & Development (Quarter)
2.15M2.53M2.09M1.78M2.11M2.56M2.45M2.01M1.48M1.74M0.79M1.65M1.78M1.65M1.86M1.91M1.84M2.19M1.58M1.54M
Selling, General & Administrative (Quarter)
2.06M1.78M1.55M0.33M1.30M1.52M1.44M1.22M1.49M1.56M1.35M0.84M1.35M1.40M1.45M1.28M1.36M1.44M1.81M1.55M
Other Operating Expenses (Quarter)
0.12M0.12M0.15M
Operating Expenses (Quarter)
4.20M4.31M3.64M2.10M3.41M4.09M3.90M3.23M2.96M3.30M2.15M2.49M3.14M3.05M3.31M3.18M3.20M3.74M3.50M3.24M
Operating Income (Quarter)
-0.20M-4.31M-3.60M-2.10M-3.41M-4.09M-3.90M-3.23M-2.96M-3.30M-1.15M-2.49M-3.14M-3.05M-3.31M-3.18M-3.20M-3.61M-3.38M-3.09M
EBIT (Quarter)
-0.20M-4.31M-3.60M-2.10M-3.41M-4.09M-3.90M-3.23M-2.96M-3.30M-1.15M-2.49M-3.14M-3.05M-3.31M-3.18M-3.20M-3.61M-3.38M-3.09M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.04M0.03M0.04M0.04M0.04M0.09M0.25M0.43M0.51M0.45M0.44M0.44M0.40M0.44M0.45M0.39M0.34M0.32M0.34M0.30M
Other Non Operating Income (Quarter)
-0.02M-0.01M-0.01M-0.01M-0.01M-0.03M-0.01M-0.19M-0.46M-0.02M-0.01M-0.00M-0.02M-0.02M0.01M0.46M0.00M952.00-0.01M0.03M
Net income details
EBT (Quarter)
-0.23M-4.34M-4.67M-2.10M-3.58M-4.18M-4.53M-3.00M-3.22M-3.06M-1.49M-85.42M-2.82M-3.17M-2.93M-3.05M-3.25M-3.61M-3.21M-2.79M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
-0.19M-4.28M-3.58M-2.08M-3.39M-4.03M-3.65M-3.02M-2.92M-2.87M-0.72M-2.05M-2.75M-2.63M-2.84M-2.81M-2.86M-3.28M-3.05M-2.80M
Income from Continuing Operations (Quarter)
-0.23M-4.34M-4.67M-2.10M-3.58M-4.18M-4.53M-3.00M-3.22M-3.06M-1.49M-85.42M-2.82M-3.17M-2.93M-3.05M-3.25M-3.61M-3.21M-2.79M
Consolidated Net Income (Quarter)
-0.23M-4.34M-4.67M-2.10M-3.58M-4.18M-4.53M-3.00M-3.22M-3.06M-1.49M-85.42M-2.82M-3.17M-2.93M-3.05M-3.25M-3.61M-3.21M-2.79M
Income towards Parent Company (Quarter)
-0.23M-4.34M-4.67M-2.10M-3.58M-4.18M-4.53M-3.00M-3.22M-3.06M-1.49M-85.42M-2.82M-3.17M-2.93M-3.05M-3.25M-3.61M-3.21M-2.79M
Net Income towards Common Stockholders (Quarter)
-0.23M-4.34M-4.67M-2.10M-3.58M-4.18M-4.53M-3.00M-3.22M-3.06M-1.49M-85.42M-2.82M-3.17M-2.93M-3.05M-3.25M-3.61M-3.21M-2.79M
Additional items
EPS (Basic) (Quarter)
0.00-0.09-0.10-0.04-0.07-0.09-0.09-0.06-0.07-0.06-0.03-1.74-0.06-0.06-0.06-0.06-0.07-0.07-0.07-0.06
EPS (Diluted) (Quarter)
-0.09-0.10-0.04-0.07-0.09-0.09-0.06-0.07-0.06-0.03-1.74-0.06-0.06-0.06-0.06-0.07-0.07-0.07-0.06
Shares Outstanding (Quarter)
47.54M48.80M48.99M48.60M49.04M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.06M
Shares Outstanding (Diluted) (Quarter)
48.80M48.99M48.60M49.04M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.05M49.06M
EBITDA (Quarter)
-0.20M-4.31M-3.60M-2.10M-3.41M-4.09M-3.90M-3.23M-2.96M-3.30M-1.15M-2.49M-3.14M-3.05M-3.31M-3.18M-3.20M-3.61M-3.38M-3.09M
Interest Expenses (Quarter)
0.06M0.06M1.11M0.03M0.21M0.18M0.89M0.20M0.76M0.21M0.78M83.37M0.08M0.56M0.07M0.26M0.39M0.33M0.17M0.00M
Tax Rate (Quarter)